x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Welcome to Supply-Chain360, your all-in-one source for actual insights into the world of SCM!

Ralph Leyendecker

Here, we explore the latest innovations, technologies, and strategies transforming the global supply chain landscape.From BANI to generative AI and automation to sustainability and risk management, our content covers everything you need to stay ahead in the dynamic world of SCM & Logistics.Whether you"re a professional, a student, or just curious about supply chains, tune in for in-depth discussions, expert interviews, and actionable tips to optimize your operations - or just learn

business management

All Episodes

8:07

Chokepoints After Davos: What Great-Power Politics...

Welcome to Supply-Chain360, your all-in-one source... ·

2026/03/15

In this episode, I follow up on Davos 2026 by shifting from speeches and symbolism to the physical realities of global supply chains. The focus is on chokepoints: the Red Sea, Suez, Hormuz, and Taiwan, and on what happens when great-power politics starts to narrow the corridors, systems, and dependencies that modern industries rely on.I look at how recent developments have moved from rhetoric into operating conditions: fragile reopenings, renewed disruptions, and rising uncertainty around routes,

en

17:08

After Davos: Great-Power Theater, Middle-Power...

Welcome to Supply-Chain360, your all-in-one source... ·

2026/01/23

In this episode, I look at Davos 2026 not as a media show, but as a live stress test of the global order.From Merz’ “age of great powers” narrative to Trump’s tariff threats, Greenland remarks, and pressure over U.S. bonds, Davos made one thing clear: the world is being run more openly as a great-power game again, and middle powers, especially in Europe, are caught in the squeeze.I translate this into the language of pharma and healthcare supply chains.We explore how tariffs, sanctions, export

en

15:13

From Country Crisis to Risk Portfolio – How Pharma...

Welcome to Supply-Chain360, your all-in-one source... ·

2026/01/19

In this episode, I move beyond “one crisis at a time” and look at geopolitics through the lens of a risk portfolio for pharma and med-tech supply chains. Starting from recent events like Venezuela, the Red Sea, Taiwan, and Europe’s energy debate, I sketch a simple way to map exposure versus geopolitical fragility – not as a theoretical exercise, but as a practical tool for network and governance decisions.I talk about what leaders can actually control: where buffers sit, how contracts handle

en

11:53

Venezuela and the BANI World – Implications for...

Welcome to Supply-Chain360, your all-in-one source... ·

2026/01/05

In this episode, I unpack the recent U.S. military operation that led to Nicolás Maduro’s capture and ongoing narco-terrorism proceedings in New York, and look at what this actually means for health and pharma supply chains in and around Venezuela.Rather than debating the politics, I focus on access to medicines, sanctions and logistics friction, and two working scenarios: a managed transition with selective relief versus a prolonged standoff where Venezuela remains a high-friction, low-priority

en

1:29

Holiday Message – Merry Christmas and see you in 2026!

Welcome to Supply-Chain360, your all-in-one source... ·

2025/12/22

This short holiday episode is a quick thank-you from me to you before I step away for a year-end break. I share a few reflections on this past year in pharma supply chains and what’s coming next for the podcast, then hit pause until the new year.Wishing you a Merry Christmas, and a healthy start into the new year. See you soon in the next season of Supply Chain 360.

en

9:10

From Signals to Action – SOPs and Response Playbooks...

Welcome to Supply-Chain360, your all-in-one source... ·

2025/12/15

In this episode of Supply Chain 360, we complete the arc from scenarios to signals to action. After building an early-warning radar for your pharma supply chain, the next question is: what happens when a signal actually flashes red?We explore how to turn early warnings into fast, coordinated responses using lean, scenario-specific SOPs – response playbooks. Instead of long policy documents, these mini-SOPs define, on a single page:which triggers matter,what options you have,who owns each action,

en

8:51

From Scenarios to Signals – Building an Early-Warning...

Welcome to Supply-Chain360, your all-in-one source... ·

2025/12/08

In this episode of Supply Chain 360, we move one step further along the BANI journey: from imagining possible futures to actually seeing them coming.Building on the previous episode on scenario planning, we explore how pharma organizations can turn scenarios into a practical early-warning system – a simple risk radar that helps you act before disruption fully hits.We look at how to define meaningful signals for your key scenarios: creeping lead times, recurring minor quality issues, lane performance

en

7:14

From Gut Feeling to Scenarios – Preparing your Pharma...

Welcome to Supply-Chain360, your all-in-one source... ·

2025/12/01

In this episode of Supply Chain 360, we move from forecasting to future-proofing. Instead of asking “What’s the plan?”, we ask a more powerful question: “What if?”We explore how simple, practical scenario planning can help pharma supply chains prepare for the unexpected. From export restrictions and supplier failures to regulatory changes or a sudden surge in demand when a new use for a drug is approved earlier than planned.You’ll hear how to:Work with one time horizon and just a few focused

en

4:38

Leading in the BANI Decade — How Supply Chains Evolve...

Welcome to Supply-Chain360, your all-in-one source... ·

2025/11/24

In this final episode of the BANI mini-series on Supply Chain 360, we shift the focus from systems to the people who run them: leaders.We revisit what it means to operate in a world that is brittle, anxious, nonlinear, and incomprehensible, and explore why supply chains only become truly viable when leadership mindsets evolve. This episode looks at how the best leaders move from control to composure, from rigid plans to adaptive thinking, and from managing risk to learning from it.We discuss the

en

5:13

White Swans in Plain Sight — Europe’s Industrial...

Welcome to Supply-Chain360, your all-in-one source... ·

2025/11/17

In this episode of Supply Chain 360, part of the BANI mini-series, we explore a major shift that isn’t a sudden shock or black-swan event, but a white swan: a visible, predictable transformation that’s already reshaping Europe’s industrial landscape.Recent data shows that around 70% of energy-intensive companies are moving investments out of Germany, driven by rising energy costs, CO₂ pricing, political uncertainty, and slowing demand. This includes global players like ArcelorMittal, redirecting

en

4:41

Enablement — Empowering People and Systems to Adapt...

Welcome to Supply-Chain360, your all-in-one source... ·

2025/11/10

In this episode of Supply Chain 360, part of the ongoing BANI mini-series, we explore the fourth and final CORE pillar: Enablement - the force that turns strategy into motion.In a world that’s brittle, anxious, nonlinear, and incomprehensible, enablement is what transforms information into action. It’s not just about tools or training, it’s about trust, confidence, and culture. When people are empowered with data they can use, systems they can trust, and the freedom to act within clear boundaries,

en

4:08

Risk — Intelligence Over Insurance in Pharma Supply...

Welcome to Supply-Chain360, your all-in-one source... ·

2025/11/03

In this episode of Supply Chain 360, part of our BANI mini-series, we unpack the third CORE pillar: Risk. In a world that’s brittle, anxious, nonlinear, and incomprehensible, traditional “risk management” as a checklist or insurance policy isn’t enough. Today’s disruptions, cyber events, trade shifts, API shortages, extreme weather, don’t arrive one at a time; they overlap, cascade, and amplify.We reframe risk as intelligence: something to sense early, understand quickly, and act on decisively

en

5:34

Orchestration — Turning Chaos into Coordination in...

Welcome to Supply-Chain360, your all-in-one source... ·

2025/10/27

In this episode of Supply Chain 360, part of the ongoing BANI mini-series, we explore the second CORE pillar: Orchestration — the art of turning complexity into coordination.Pharma supply chains are filled with hundreds of moving parts — suppliers, regulators, logistics partners, and manufacturers — all operating on their own timelines. True orchestration is about creating alignment along the entire value chain, bringing people, processes, and systems into rhythm even when the world feels out of

en

3:58

Complexity — The Invisible Web of Modern Pharma...

Welcome to Supply-Chain360, your all-in-one source... ·

2025/10/22

In this episode of Supply Chain 360, part of the ongoing BANI mini-series, we dive into the first CORE pillar: Complexity. Pharma supply chains aren’t simple, linear systems, they’re intricate networks of suppliers, regulators, manufacturers, and logistics partners, all bound together by interdependence and risk. The more we’ve optimized for efficiency, the more brittle those networks have become.This episode explores how leaders can move from fighting complexity to understanding and orchestrating

en

3:53

Beyond Resilience — The Age of Viability in Pharma...

Welcome to Supply-Chain360, your all-in-one source... ·

2025/10/14

In this episode of Supply Chain 360, we continue our BANI mini-series — exploring how to lead and build in a world that’s brittle, anxious, nonlinear, and incomprehensible.For years, resilience was the ultimate goal in supply-chain management. But in today’s constant state of disruption, bouncing back isn’t enough. It’s time to move toward viability — the ability to adapt, evolve, and stay relevant no matter what happens next.We unpack what “viability” really means for pharma supply chains, why

en

5:13

Navigating Pharma Supply Chains through a BANI World

Welcome to Supply-Chain360, your all-in-one source... ·

2025/10/13

This kickoff to my BANI mini‑series unpacks how brittle, anxious, non‑linear and incomprehensible dynamics are reshaping pharma supply chains. We discuss real‑world brittleness: a 7.4‑magnitude earthquake in Japan that halted chip production and ground Detroit’s auto assembly, and a software update that locked up millions of computers and grounded. We examine how U.S. tariffs on Chinese imports have pushed logistics costs up 10–15 % for 60 % of companies and how Houthi attacks have closed the Red

en

2:18

Responsible AI: Are we losing the Human in the Process?

Welcome to Supply-Chain360, your all-in-one source... ·

2025/10/13

In this episode, I reflect on the growing trend of AI being used to cut jobs, often without a clear plan for reskilling or redeployment. Triggered by a recent New York Times article mentioning layoffs at companies like Microsoft and Recruit Holdings, I question whether we’re losing the human in the process. AI isn’t the problem. It’s how we choose to implement it that matters. Here is the link to my whitepaper on this topic: The Social Impact of AI: Rethinking Corporate Responsibility in the Age of

en

6:04

Talent Management - A balanced approach to Leadership...

Welcome to Supply-Chain360, your all-in-one source... ·

2025/10/13

Welcome to this special episode of my podcast, where I explore the critical aspects of Talent Management—not just as a process of developing leaders but as a balanced framework that equally emphasizes followership development. Using insights from various scholarly and professional sources, I aim to reshape how organizations think about managing their most vital asset: People.

en

5:54

Artificial Intelligence (AI) in Pharmaceutical...

Welcome to Supply-Chain360, your all-in-one source... ·

2025/10/13

Today's episode focuses on the role of AI in Pharmaceutical Manufacturing, specifically how it is powering personalized medicine. We will explore AI's impact today and what the future looks like by 2030, with technologies like digital twins driving efficiency and precision in drug development.

en

6:12

Supply Chain Quo Vadis - How identified challenges...

Welcome to Supply-Chain360, your all-in-one source... ·

2025/10/13

In this episode we will dive into how identified challenges in supply chain management become opportunities - or maybe not?Curious? Tune in and find out.

en

21 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...